Comparison of the clinical effectiveness of tumour necrosis factor inhibitors and abatacept after insufficient response to tocilizumab in patients with rheumatoid arthritis
Crossref DOI link: https://doi.org/10.1007/s10067-016-3227-8
Published Online: 2016-03-12
Published Print: 2016-11
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Akiyama, Mitsuhiro
Kaneko, Yuko
Kondo, Harumi
Takeuchi, Tsutomu
Text and Data Mining valid from 2016-03-12